Window to Japan
https://bio.nikkeibp.co.jp/atcl/news/p1/23/06/21/10838/ Shimadzu Corporation begins test marketing of its “Intestinal Bacteria
https://bio.nikkeibp.co.jp/atcl/news/p1/23/06/21/10838/ Shimadzu Corporation begins test marketing of its “Intestinal Bacteria
https://www.nedo.go.jp/news/prehttps://fermelanta.com/ss/AA5_101655.html https://fermelanta.com There are many rare and useful components in
https://www.nedo.go.jp/news/press/AA5_101659.html NEDO supports five R&D themes for the “Study and
https://www.nedo.go.jp/news/press/AA5_101666.html As part of NEDO’s “Development of Fuel Ammonia Utilization
https://bio.nikkeibp.co.jp/atcl/column/16/021500017/062100285/ The company is working on the development of a
https://bio.nikkeibp.co.jp/atcl/news/p1/23/06/27/10855/ Qualipse, a developer of iPS cell-derived cardiomyocyte sheets, was
https://bio.nikkeibp.co.jp/atcl/news/p1/23/06/27/10852/ Regional Fish and NTT announced the establishment of a
https://www.nedo.go.jp/news/press/AA5_101665.html NEDO has begun development and demonstration of applications and